Interaction of dexrazoxane with anticancer drugs

Interaction of dexrazoxane with anticancer drugs

Show other versions (2)

This thesis work consists of two major projects. In the first project the effects of combination of the cardioprotective agent, dexrazoxane, with the anticancer drugs mafosfamide, 5-fluorouracil, vinblastine, doxorubicin, daunorubicin, mitoxantrone and bleomycin were tested on Chinese hamster ovary...

Full description

Bibliographic Details
Main Author:	Kozlowska, Hanna
Language:	en_US
Published:	2007
Online Access:	http://hdl.handle.net/1993/1298

Similar Items

Interaction of dexrazoxane with anticancer drugs
by: Kozlowska, Hanna
Published: (2007)

Interaction of dexrazoxane with anticancer drugs
by: Kozlowska, Hanna
Published: (2007)

Interaction of topoisomerase II-targeted anticancer agents with the doxorubicin cardioprotective drug dexrazoxane, and synthesis of a dexrazoxane analog
by: Tran, Khanh Tuan
Published: (2007)

Interaction of topoisomerase II-targeted anticancer agents with the doxorubicin cardioprotective drug dexrazoxane, and synthesis of a dexrazoxane analog
by: Tran, Khanh Tuan
Published: (2007)

Interaction of topoisomerase II-targeted anticancer agents with the doxorubicin cardioprotective drug dexrazoxane, and synthesis of a dexrazoxane analog
by: Tran, Khanh Tuan
Published: (2007)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Anthracycline extravasation injuries: management with dexrazoxane
by: Karin Jordan, et al.
Published: (2009-05-01)

The metabolism of razoxane and dexrazoxane in the Sprague-Dawley rat
by: Aoyama, Ronald G.
Published: (2007)

The metabolism of razoxane and dexrazoxane in the Sprague-Dawley rat
by: Aoyama, Ronald G.
Published: (2007)

The metabolism of razoxane and dexrazoxane in the Sprague-Dawley rat
by: Aoyama, Ronald G.
Published: (2007)

Dexrazoxane for the treatment of chemotherapy-related side effects
by: Langer SW
Published: (2014-09-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
by: Pankit Vachhani, et al.
Published: (2017-01-01)

Characterization of growth, apoptosis, and differentiation of CHO and human erythroleukemic K562 cells exposed to dexrazoxane, and the selection of a dexrazoxane-resistant K562 cell line
by: Abram, Michael E.
Published: (2007)

Characterization of growth, apoptosis, and differentiation of CHO and human erythroleukemic K562 cells exposed to dexrazoxane, and the selection of a dexrazoxane-resistant K562 cell line
by: Abram, Michael E.
Published: (2007)

Characterization of growth, apoptosis, and differentiation of CHO and human erythroleukemic K562 cells exposed to dexrazoxane, and the selection of a dexrazoxane-resistant K562 cell line
by: Abram, Michael E.
Published: (2007)

Mechanism of action of dexrazoxane and its protection in cardiotoxicity induced by doxorubicin
by: Schnabl, Kareena Leanne
Published: (2013)

Mechanism of action of dexrazoxane and its protection in cardiotoxicity induced by doxorubicin
by: Schnabl, Kareena Leanne
Published: (2013)

Effects of the Cardioprotective Drugs Dexrazoxane and ADR-925 on Doxorubicin Induced Ca2+ Release from the Sarcoplasmic Reticulum
by: Herzinger, Thomas Andreas
Published: (1996)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
by: Yang QuanJun, et al.
Published: (2017-01-01)

Utility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ Cells.
by: Sabry M Attia, et al.
Published: (2016-01-01)

Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs.
by: Pranitha Kamat, et al.
Published: (2016-01-01)

Correction: Utility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ Cells.
by: Sabry M Attia, et al.
Published: (2016-01-01)

Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice.
by: Jenna Kropp, et al.
Published: (2015-01-01)

Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p
by: Xiaoxue Yu, et al.
Published: (2020-01-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

Effect of Sodium 2,3-Dimercaptopropane-1-Sulphonate (DMPS) on Chronic Daunorubicin Toxicity in Rabbits: Comparison with Dexrazoxane
by: Radomír Hrdina, et al.
Published: (2002-01-01)

Metabolism of the doxorubicin cardioprotective agent dexrazoxane and its one ring-opened intermediates B and C to ADR-925
by: Schroeder, Patricia E.
Published: (2013)

Metabolism of the doxorubicin cardioprotective agent dexrazoxane and its one ring-opened intermediates B and C to ADR-925
by: Schroeder, Patricia E.
Published: (2013)

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
by: Concetta Panebianco, et al.
Published: (2018-05-01)

Genetic Interactions of STAT3 and Anticancer Drug Development
by: Bingliang Fang
Published: (2014-03-01)

DNA and DNA-Interacting Proteins as Anticancer Drug Targets
by: Punchihewa, Chandanamalie
Published: (2006)

Anticancer Drugs
Published: (2019)

Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
by: Sarah Dewilde, et al.
Published: (2020-02-01)

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
by: Jieli Li, et al.
Published: (2020-01-01)

Função sistólica do ventrículo esquerdo pela ecocardiografia em crianças e adolescentes com osteossarcoma tratados com doxorrubicina com e sem dexrazoxane Left ventricular systolic function assessed by echocardiography in children and adolescents with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane
by: Ranulfo Pinheiro de Matos Neto, et al.
Published: (2006-12-01)

Interactions between traditional chinese medicine and anticancer drugs in chemotherapy
by: Zhi-Jie Ding, et al.
Published: (2017-01-01)

The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study
by: Weilan WANG, et al.
Published: (2019-03-01)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
by: Lisa M. Kopp, et al.
Published: (2019-10-01)

Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model
by: Cory V. Noel, et al.
Published: (2021-06-01)